https://www.avient.com/sites/default/files/2023-05/Mevopur Healthcare Colorants and Formulations Amber for Pharma Application Bulletin.pdf
An addition to the
Mevopur™ portfolio is a pre-tested amber
concentrate for PET vials, bottles and other
packaging products.
https://www.avient.com/sites/default/files/2021-04/versaflex-computer-mouse-case-study.pdf
In
addition, the profit margin on this product was about
30% higher than that of other models.
https://www.avient.com/sites/default/files/2020-09/oncap-hc-product-bulletin.pdf
KEY CHARACTERISTICS
• Formulated specifically for healthcare product
applications
• Wide portfolio of polymer additive solutions,
including:
- Antimicrobial technology
- Surface energy modification, including
low retention
- Authentication technology
- Lasermarking
- Sterilization and content protection
- Processing optimization
- FDA compliant resin and color changeover
solutions
• OnCap HC Plus certified for USP Class VI and ISO
10993 bio-compatibility requirements; includes
anti-oxidant, lasermarking, antimicrobial,
radiopacifier, anti-stat, and polymer and
gamma stabilization performance additives
OnCap™ HC & OnCap™ HC Plus
Additives for Healthcare
PRODUCT BULLETIN
INDUSTRY SUPPORT
• Supported with a broad range of technical support
and services:
- Restricted medical-grade raw material
selection process
- Sampling program
- World-class FDA cGMP manufacturing facilities
- Batch traceability and formulation
lockdown systems
- FDA Drug Master Files or Medical Device
Files maintenance
MARKETS AND APPLICATIONS
OnCap HC and OnCap HC Plus Additives are an
excellent choice for medical devices and parts,
pharmaceutical or cosmetic packaging, and many other
healthcare related polymer applications.
https://www.avient.com/sites/default/files/2024-11/Ballistic Panel Infographic.pdf
Composite ballistic panels provide several advantages, including:
Homes
4%
Government
Buildings
40%
Office
Buildings
16%
Banks
25%
Other
25%
Where are ballistic
composite panels used?
https://www.avient.com/sites/default/files/2021-08/20210802-business-profile.pdf
FYE - Financial Year End
Note :
- The information contained in this product is collated from lodgements filed with ACRA, and/or information collected by other government sources
https://www.avient.com/sites/default/files/resources/11.30.18%2520Investor%2520Presentation%2520V1.pdf
Investor Day
POLYONE
I N V E S T O R
P R E S E N T A T I O N
N O V E M B E R 2 0 1 8
FORWARD LOOKING STATEMENTS
PolyOne Corporation 2
In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements”
within the meaning of the Private Securities Litigation Reform Act of 1995.
They use words such as “will,” “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” and other
words and terms of similar meaning in connection with any discussion of future operating or financial performance and/or sales.
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to:
• Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the
availability and cost of credit in the future;
• The effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks;
• Changes in polymer consumption growth rates and laws and regulations regarding the disposal of plastic in jurisdictions where we
conduct business;
• Changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online;
• Fluctuations in raw material prices, quality and supply and in energy prices and supply; production outages or material costs associated
with scheduled or unscheduled maintenance programs;
• Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters;
• An inability to raise or sustain prices for products or services;
• Information systems failures and cyber attacks; and
• Other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in
interest rates and changes in the rate of inflation.
https://www.avient.com/sites/default/files/resources/PDI_Healthcare_Brochure_2011_0.pdf
PDI has extensive experience with
the testing of medical devices and
materials including:
• Catheters
• Bio-implants
• Surgical diagnostic devices
• Medical tubing
• Other disposable medical devices
Issues often arise as a result of:
• Improper design or choice of material
• The environment of exposure
• Processing conditions
World-class people and capabilities
under one roof
• Failure Analysis/Prevention
• Qualifi cation Support
• Rheology
• Polymer Characterization
• Deformulation
• Physical Testing
• Litigation Support
• Characterization of polymers in pharmaceutical
delivery systems
• Phthalate and BPA testing
C M Y K HC_Industry bulletin_PDI_fi nal.indd REMAY 78810
TR: 16.5000" x 11.6875" and 17.000" x 11.000" Digital/IAM
BL: 17.2500" x 11.9375"
FINAL: 8.2500" x 11.6875" and 8.500" x 11.000"
i n
Polymer Diagnostics Inc.
PDI has extensive experience with
the testing of medical devices and
materials including:
• Catheters
• Bio-implants
• Surgical diagnostic devices
• Medical tubing
• Other disposable medical devices
Issues often arise as a result of:
• Improper design or choice of material
• The environment of exposure
• Processing conditions
World-class people and capabilities
under one roof
• Failure Analysis/Prevention
• Qualifi cation Support
• Rheology
• Polymer Characterization
• Deformulation
• Physical Testing
• Litigation Support
• Characterization of polymers in pharmaceutical
delivery systems
• Phthalate and BPA testing
C M Y K HC_Industry bulletin_PDI_fi nal.indd REMAY 78810
TR: 16.5000" x 11.6875" and 17.000" x 11.000" Digital/IAM
BL: 17.2500" x 11.9375"
FINAL: 8.2500" x 11.6875" and 8.500" x 11.000"
i n
www.polymerdiagnostics.com
Industr y Bul let in
Comprehensive consulting and testing
expertise for medical materials and
device companies
Committed to Growing with the Medical Industry
Since 2009, PDI has invested over $2 million to improve and extend our capabilities to serve our medical
materials and device clients.
https://www.avient.com/sites/default/files/2020-08/wilflex-ghosting-tips-techniques.pdf
Even if all the other factors are in place, the chances of
experiencing ghosting are drastically diminished if no
humidity is present.
https://www.avient.com/sites/default/files/2022-09/PREPERM for 5G Application Bulletin %281%29.pdf
PREPERM solutions enable faster,
safer and more reliable connections—in antennas,
lenses, screws or other RF parts
https://www.avient.com/sites/default/files/2020-09/crtm-panel-product-bulletin-2020.pdf
KEY CHARACTERISTICS
Avient CRTM panels offer significant benefits
to customers, including:
• Superior strength to weight ratio
• �Unlimited length capability; widths
up to 108"
• �Thermal insulation
• Ultra-low thermal conductivity
• �Customized density, thickness, weight
and color
• �Vibration damping and acoustic insulation
• Chemical and corrosion resistance
• Consistent cross-sections and quality
PRODUCT BULLETIN
Other thicknesses/architectures are available.